RAYMOND JAMES & ASSOCIATES - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 105 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.19 and the average weighting 0.2%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$201,000
+16.2%
40,198
+64.3%
0.00%
Q1 2021$173,000
-78.1%
24,460
-80.6%
0.00%
-100.0%
Q4 2020$790,000
-0.8%
126,208
-21.0%
0.00%0.0%
Q3 2020$796,000
+325.7%
159,762
+345.0%
0.00%
Q2 2020$187,000
+61.2%
35,898
-2.8%
0.00%
Q1 2020$116,000
-38.0%
36,948
-20.3%
0.00%
Q4 2019$187,000
-25.8%
46,348
-20.5%
0.00%
Q3 2019$252,000
-25.0%
58,323
-30.7%
0.00%
Q2 2019$336,000
-30.3%
84,123
-6.4%
0.00%
-100.0%
Q1 2019$482,000
-4.6%
89,865
-8.8%
0.00%0.0%
Q4 2018$505,000
-47.2%
98,528
-0.1%
0.00%0.0%
Q3 2018$957,000
+6.0%
98,675
+11.4%
0.00%
-50.0%
Q2 2018$903,000
-21.5%
88,573
+0.1%
0.00%0.0%
Q1 2018$1,150,000
+166.2%
88,494
+266.3%
0.00%
+100.0%
Q4 2017$432,000
+49.5%
24,157
+109.6%
0.00%0.0%
Q3 2017$289,00011,5250.00%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,609,398$7,821,0001.64%
Telemetry Investments, L.L.C. 242,514$1,179,0001.59%
Omega Fund Management, LLC 2,606,809$12,669,0001.42%
Bruce & Co., Inc. 1,343,312$6,528,0001.39%
1492 Capital Management LLC 488,309$2,373,0001.20%
Abingworth LLP 1,041,131$5,060,0001.15%
Trellus Management Company, LLC 295,000$1,434,0001.04%
Worth Venture Partners, LLC 389,440$1,893,0000.85%
CM Management, LLC 200,000$972,0000.72%
GENERAL AMERICAN INVESTORS CO INC 1,112,658$5,408,0000.46%
View complete list of PARATEK PHARMACEUTICALS INC shareholders